HomeCompareHOLX vs NOC

HOLX vs NOC: Dividend Comparison 2026

HOLX yields 2.65% · NOC yields 1.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NOC wins by $88.4K in total portfolio value· pulled ahead in Year 2
10 years
HOLX
HOLX
● Live price
2.65%
Share price
$75.55
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.6K
Annual income
$314.03
Full HOLX calculator →
NOC
NOC
● Live price
1.38%
Share price
$671.59
Annual div
$9.24
5Y div CAGR
58%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$112.0K
Annual income
$45,261.73
Full NOC calculator →

Portfolio growth — HOLX vs NOC

📍 NOC pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHOLXNOC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HOLX + NOC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HOLX pays
NOC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HOLX
Annual income on $10K today (after 15% tax)
$225.02/yr
After 10yr DRIP, annual income (after tax)
$266.93/yr
NOC
Annual income on $10K today (after 15% tax)
$116.95/yr
After 10yr DRIP, annual income (after tax)
$38,472.47/yr
At 15% tax rate, NOC beats the other by $38,205.55/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HOLX + NOC for your $10,000?

HOLX: 50%NOC: 50%
100% NOC50/50100% HOLX
Portfolio after 10yr
$67.8K
Annual income
$22,787.88/yr
Blended yield
33.60%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NOC right now

HOLX
Analyst Ratings
18
Buy
23
Hold
1
Sell
Consensus: Hold
Price Target
$77.80
+3.0% upside vs current
Range: $76.00 — $79.00
Altman Z
4.2
Piotroski
7/9
NOC
Analyst Ratings
20
Buy
14
Hold
1
Sell
Consensus: Buy
Price Target
$736.31
+9.6% upside vs current
Range: $623.00 — $815.00
Altman Z
3.3
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HOLX buys
0
NOC buys
0
No recent congressional trades found for HOLX or NOC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHOLXNOC
Forward yield2.65%1.38%
Annual dividend / share$2.00$9.24
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%58%
Portfolio after 10y$23.6K$112.0K
Annual income after 10y$314.03$45,261.73
Total dividends collected$2.9K$85.7K
Payment frequencyquarterlyquarterly
SectorHealthcareIndustrials
Analyst consensusHoldBuy
Analyst price target$77.80$736.31

Year-by-year: HOLX vs NOC ($10,000, DRIP)

YearHOLX PortfolioHOLX Income/yrNOC PortfolioNOC Income/yrGap
1$10,965$264.73$10,917$217.38+$48.00HOLX
2← crossover$12,004$271.27$12,032$350.44$28.00NOC
3$13,121$277.55$13,445$570.31$324.00NOC
4$14,323$283.54$15,327$941.01$1.0KNOC
5$15,615$289.27$17,984$1,584.04$2.4KNOC
6$17,003$294.73$21,987$2,744.54$5.0KNOC
7$18,493$299.93$28,481$4,954.86$10.0KNOC
8$20,093$304.87$39,952$9,477.48$19.9KNOC
9$21,809$309.57$62,380$19,631.40$40.6KNOC
10$23,649$314.03$112,009$45,261.73$88.4KNOC

HOLX vs NOC: Complete Analysis 2026

HOLXHealthcare

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Full HOLX Calculator →

NOCIndustrials

Northrop Grumman Corporation operates as an aerospace and defense company worldwide. The company's Aeronautics Systems segment designs, develops, manufactures, integrates, and sustains aircraft systems. This segment also offers unmanned autonomous aircraft systems, including high-altitude long-endurance strategic ISR systems and vertical take-off and landing tactical ISR systems; and strategic long-range strike aircraft, tactical fighter and air dominance aircraft, and airborne battle management and command and control systems. Its Defense Systems segment designs, develops, and produces weapons and mission systems. It offers products and services, such as integrated battle management systems, weapons systems and aircraft, and mission systems. This segment also provides command and control and weapons systems, including munitions and missiles; precision strike weapons; propulsion, such as air-breathing and hypersonic systems; gun systems and precision munitions; life cycle service and support for software, weapons systems, and aircraft; and logistics support, sustainment, operation, and modernization for air, sea, and ground systems. The company's Mission Systems segment offers cyber, command, control, communications and computers, intelligence, surveillance, and reconnaissance systems; radar, electro-optical/infrared and acoustic sensors; electronic warfare systems; advanced communications and network systems; cyber solutions; intelligence processing systems; navigation; and maritime power, propulsion, and payload launch systems. This segment also provides airborne multifunction sensors; maritime/land systems and sensors; navigation, targeting, and survivability solutions; and networked information solutions. Its Space Systems segment offers satellites and payloads; ground systems; missile defense systems and interceptors; launch vehicles and related propulsion systems; and strategic missiles. The company was founded in 1939 and is based in Falls Church, Virginia.

Full NOC Calculator →
📬

Get this HOLX vs NOC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HOLX vs SCHDHOLX vs JEPIHOLX vs OHOLX vs KOHOLX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.